Global /United States /Healthcare /Medical Devices /IDXX
chevron_leftBack
IDEXX Laboratories, Inc. logo

IDEXX Laboratories, Inc.

IDXX
NASDAQ: IDXX Delayed
553.66USD -2.6%
As of 8 July 2026, IDEXX Laboratories, Inc. has a market cap of $43.97B USD, ranking #556 globally and #253 in the United States. It ranks #49 in the Healthcare sector, and #13 in the Medical Devices industry.
Global Rank
556
1d: 0
1w: +4
1m: -
Country Rank
253
1d: 0
1w: +6
1m: -
Sector Rank
49
1d: 0
1w: 0
1m: -
Industry Rank
13
1d: 0
1w: 0
1m: -
Key Stats
Market Cap
$43.97BUSD
Enterprise Value
$44.27BUSD
Revenue (TTM)
$4.3BUSD
EBITDA (TTM)
$1.51BUSD
Net Income (TTM)
$1.06BUSD
EBITDA Margin
35%
Profit Margin
25%
PE Ratio
42.3
Forward PE
38.2
PS Ratio
10.1
PB Ratio
28.2
EV/EBITDA
29.4
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Jonathan Mazelsky open_in_new
Employees
11,000
Founded
1983
IPO
21 Jun 1991
Website
idexx.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-2.6% -4.3% -0.8% -19% -13% 28%

News

Loading...

IDXX Analyst Forecasts

Loading...

Markets

Exchange Ticker Price
NASDAQ
MIC: XNAS
PRIMARY
IDXX
IDEXX Laboratories Inc
ISIN: US45168D1046
Shares Out.:
78.883M1 Shares Float: 78.582M2
TV:
SA:
YF:
GF:
NQ:
BA:
MS:
553.66 USD
London Stock Exchange
MIC: XLON
0J8P
IDEXX Laboratories Inc
ISIN: US45168D1046
TV:
SA:
YF:
GF:
BA:
MS:
550.33 USD
Borsa Italiana
MIC: XMIL
1IDXX
IDEXX Laboratories Inc
ISIN: US45168D1046
TV:
SA:
YF:
GF:
BA:
MS:
485.80 EUR
Show all 8 markets
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Similar Companies

Industry: Medical Devices (United States)
Name
Market Cap diff.
PE
$173.27B
294%
25.8
$160.73B
266%
56.7
$159.07B
262%
25.6
DHR
$126.55B
188%
34.7
SYK
$120.69B
174%
38.3
$84.93B
93%
24.5
Industry: Medical Devices (Global)
Name
Market Cap diff.
PE
MDT
$101.9B
132%
22.2
$96.29B
84.32B EUR
119%
36.7
7741
$60.71B
9.83T JPY
38%
40.0
$44.92B
39.34B EUR
2.2%
18.7
ALC
$35.9B
28.99B CHF
-18%
37.9
$29.97B
203.66B CNY
-32%
26.0
chevron_leftBack